Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR ...
This year’s Nordic Ambassadors' forum focused on fostering sustainable partnerships between the Nordic region and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback